248 related articles for article (PubMed ID: 34036449)
1. Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements.
Mikolajczak R; Huclier-Markai S; Alliot C; Haddad F; Szikra D; Forgacs V; Garnuszek P
EJNMMI Radiopharm Chem; 2021 May; 6(1):19. PubMed ID: 34036449
[TBL] [Abstract][Full Text] [Related]
2. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.
Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F
Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573
[TBL] [Abstract][Full Text] [Related]
3. Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.
Ioannidis I; Lefkaritis G; Georgiades SN; Pashalidis I; Kontoghiorghes GJ
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892142
[TBL] [Abstract][Full Text] [Related]
4. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
5.
Dellepiane G; Casolaro P; Mateu I; Scampoli P; Voeten N; Braccini S
Appl Radiat Isot; 2022 Nov; 189():110428. PubMed ID: 36049443
[TBL] [Abstract][Full Text] [Related]
6. Interdisciplinary Tasks in the Cyclotron Production of Radiometals for Medical Applications. The Case of
Boschi A; Martini P; Costa V; Pagnoni A; Uccelli L
Molecules; 2019 Jan; 24(3):. PubMed ID: 30691170
[TBL] [Abstract][Full Text] [Related]
7. Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets.
Loveless CS; Blanco JR; Diehl GL; Elbahrawi RT; Carzaniga TS; Braccini S; Lapi SE
J Nucl Med; 2021 Jan; 62(1):131-136. PubMed ID: 32620699
[TBL] [Abstract][Full Text] [Related]
8. Fifty Shades of Scandium: Comparative Study of PET Capabilities Using Sc-43 and Sc-44 with Respect to Conventional Clinical Radionuclides.
Lima TVM; Gnesin S; Strobel K; Pérez MDS; Roos JE; Müller C; van der Meulen NP
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679525
[TBL] [Abstract][Full Text] [Related]
9. Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47.
Chernysheva M; Loveless SC; Brossard T; Becker K; Cingoranelli S; Aluicio-Sarduy E; Song J; Ellison P; Nolen J; Rotsch DA; Lapi SE; Engle JW
Curr Radiopharm; 2021; 14(4):359-373. PubMed ID: 33438551
[TBL] [Abstract][Full Text] [Related]
10. Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals.
Majkowska-Pilip A; Bilewicz A
J Inorg Biochem; 2011 Feb; 105(2):313-20. PubMed ID: 21194633
[TBL] [Abstract][Full Text] [Related]
11. IAEA Activities on
Jalilian AR; Gizawy MA; Alliot C; Takacs S; Chakarborty S; Rovais MRA; Pupillo G; Nagatsu K; Park JH; Khandaker MU; Mikolajczak R; Bilewicz A; Okarvi S; Gagnon K; Al Rayyes AH; Lapi SE; Starovoitova V; Korde A; Osso JA
Curr Radiopharm; 2021; 14(4):306-314. PubMed ID: 32988359
[TBL] [Abstract][Full Text] [Related]
12. Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide
Loveless CS; Radford LL; Ferran SJ; Queern SL; Shepherd MR; Lapi SE
EJNMMI Res; 2019 May; 9(1):42. PubMed ID: 31098710
[TBL] [Abstract][Full Text] [Related]
13. Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.
Meier JP; Zhang HJ; Freifelder R; Bhuiyan M; Selman P; Mendez M; Kankanamalage PHA; Brossard T; Pusateri A; Tsai HM; Leoni L; Penano S; Ghosh K; Broder BA; Markiewicz E; Renne A; Stadler W; Weichselbaum R; Nolen J; Kao CM; Chitneni SK; Rotsch DA; Szmulewitz RZ; Chen CT
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630292
[TBL] [Abstract][Full Text] [Related]
14. Production and Use of the First-Row Transition Metal PET Radionuclides
Chaple IF; Lapi SE
J Nucl Med; 2018 Nov; 59(11):1655-1659. PubMed ID: 30262514
[TBL] [Abstract][Full Text] [Related]
15. Marine Exopolysaccharide Complexed With Scandium Aimed as Theranostic Agents.
Mazza M; Alliot C; Sinquin C; Colliec-Jouault S; Reiller PE; Huclier-Markai S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672781
[TBL] [Abstract][Full Text] [Related]
16. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.
Huclier-Markai S; Kerdjoudj R; Alliot C; Bonraisin AC; Michel N; Haddad F; Barbet J
Nucl Med Biol; 2014 May; 41 Suppl():e36-43. PubMed ID: 24361353
[TBL] [Abstract][Full Text] [Related]
17. Production of scandium-44 m and scandium-44 g with deuterons on calcium-44: cross section measurements and production yield calculations.
Duchemin C; Guertin A; Haddad F; Michel N; Métivier V
Phys Med Biol; 2015 Sep; 60(17):6847-64. PubMed ID: 26301533
[TBL] [Abstract][Full Text] [Related]
18. A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with
Talip Z; Favaretto C; Geistlich S; Meulen NPV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093425
[TBL] [Abstract][Full Text] [Related]
19. Current State of
Schmidt CE; Gajecki L; Deri MA; Sanders VA
Curr Radiopharm; 2023; 16(2):95-106. PubMed ID: 36372922
[TBL] [Abstract][Full Text] [Related]
20. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
